No Data
Bamboos Health Care Fiscal H1 Attributable Profit Falls as Revenue Plummets 21%
BAMBOOSHEALTH (02293.HK) reported a 40.9% drop in interim net profit to 10.1 million Hong Kong dollars, with an interim dividend of 2.5 Hong Kong cents.
Glory Exchange reported on February 26 that BAMBOOSHEALTH (02293.HK) announced its interim results for the six months ending December 31, 2024, with revenue of approximately 39.5 million HKD, a year-on-year decrease of about 20.5%; the profit before income tax was approximately 12.9 million HKD, a year-on-year decrease of about 38.6%; the profit attributable to equity holders of the company was approximately 10.1 million HKD, a year-on-year decrease of about 40.9%. The Board of Directors decided to declare an interim dividend of 10.0615 million HKD (2.5 HKD cents per ordinary share) to the company shareholders listed on the register as of the close of business on March 14, 2025 (Friday).
Express News | Bamboos Health Care - Resolved to Declare Interim Dividend of HK2.5 Cents per Share
Express News | Bamboos Health Care Holdings H1 Revenue HKD 39.5 Million
BAMBOOSHEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2024
BAMBOOSHEALTH (02293.HK) plans to hold a Board of Directors meeting on February 26 to approve the interim results.
On February 7, Gelonghui announced that BAMBOOSHEALTH (02293.HK) will hold a Board of Directors meeting on February 26, 2025 (Wednesday), aimed at (including) approving the publication of the interim performance announcement for the six months ending December 31, 2024, as well as considering the declaration of an interim dividend (if any).
Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation Is Looking A Bit Stretched At The Moment
